miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer

Approximately 75% of diagnosed breast cancer tumors are estrogen-receptor-positive tumors and are associated with a better prognosis due to response to hormonal therapies. However, around 40% of patients relapse after hormonal therapies. Genomic analysis of gene expression profiles in primary breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Mithil, Saatci, Ozge, Gupta, Gourab, Patel, Yogin, Keerthi Raja, Manikanda Raja, Li, Jie, Liu, Xinfeng, Xu, Peisheng, Wang, Hongjun, Fan, Daping, Sahin, Ozgur, Chen, Hexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331933/
https://www.ncbi.nlm.nih.gov/pubmed/35897675
http://dx.doi.org/10.3390/ijms23158086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331933/
https://www.ncbi.nlm.nih.gov/pubmed/35897675
http://dx.doi.org/10.3390/ijms23158086

Ejemplares similares